Clinical Drug Development
Queen Mary University of LondonClinical Drug Development PgDip is a postgraduate degree at Queen Mary University of London, based in Islington, taught full-time over 9 months.
About this course
The MSc in Clinical Drug Development provides students with a multidisciplinary perspective to facilitate their skills. The programme is designed for individuals who need an understanding of drug development process and provides a detailed picture of the complex and highly interrelated activities required for the development cycle for drugs and biologics, from the process of discovery to successful commercialisation.
- This programme provides students with the edge that the pharmaceutical industry requires.
- It empowers the professionals working within the field with the skills and understanding required for fast progression within the industry and contract research organisations (CROs).
Study Options
This course is available in 6 study options:
Duration: 21 Months
Qualification: PgDip
Location: Islington
Duration: 9 Months
Qualification: PgDip
Location: Islington
Duration: 4 Years
Qualification: PgDip
Location: Islington
Duration: 2 Years
Qualification: MSc
Location: Islington
Duration: 1 Year
Qualification: MSc
Location: Islington
Duration: 4 Years
Qualification: MSc
Location: Islington
Career Prospects
Graduates from this course typically go into the following occupations. Click through for salaries, employment rates and other UK degrees that lead there:
Related Courses
Course Details
- Qualification
- Postgraduate Diploma - PgDip
- Study Mode
- Full-time
- Duration
- 9 Months
- Start Date
- 2025
- Academic Year
- 2025
- Campus / Location
- Islington
- Scheme
- Postgraduate
- Subjects
- Pharmacy, pharmacology, and toxicology
2025-entry data — 2026 offers may differ